TipRanks (Wed, 10-Dec 6:25 AM ET)
Why Is Gene Therapy Focused Senti Bio Stock Falling Today?
Benzinga (Tue, 9-Dec 1:34 PM ET)
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
TipRanks (Tue, 9-Dec 1:06 PM ET)
Senti Bio’s SENTI-202 Wins Key FDA RMAT Designation: What 50% Response Rate Means for AML Therapy
Market Chameleon (Tue, 9-Dec 4:54 AM ET)
Why Is Senti Biosciences Stock (SNTI) Up Today?
TipRanks (Tue, 9-Dec 8:23 AM ET)
Market Chameleon (Tue, 9-Dec 2:54 AM ET)
Senti Biosciences Reports Promising Phase 1 Trial Results
TipRanks (Tue, 9-Dec 7:27 AM ET)
Globe Newswire (Tue, 9-Dec 7:00 AM ET)
Globe Newswire (Tue, 9-Dec 7:00 AM ET)
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Senti Biosciences trades on the NASDAQ stock market under the symbol SNTI.
As of December 12, 2025, SNTI stock price declined to $1.31 with 1,111,299 million shares trading.
SNTI has a beta of 1.67, meaning it tends to be more sensitive to market movements. SNTI has a correlation of 0.04 to the broad based SPY ETF.
SNTI has a market cap of $34.44 million. This is considered a Sub-Micro Cap stock.
Last quarter Senti Biosciences reported $0 in Revenue and -$.69 earnings per share. This fell short of revenue expectation by $-166,670 and missed earnings estimates by -$.11.
In the last 3 years, SNTI traded as high as $21.90 and as low as $1.26.
The top ETF exchange traded funds that SNTI belongs to (by Net Assets): VTI, VXF, IWC.
SNTI has underperformed the market in the last year with a price return of -76.6% while the SPY ETF gained +14.0%. SNTI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.0% and -41.3%, respectively, while the SPY returned +4.0% and -0.2%, respectively.
SNTI support price is $1.30 and resistance is $1.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNTI shares will trade within this expected range on the day.
